Search Results - "TEN BERGE, I"

Refine Results
  1. 1

    A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function by Kamburova, E. G., Koenen, H. J. P. M., Borgman, K. J. E., ten Berge, I. J., Joosten, I., Hilbrands, L. B.

    Published in American journal of transplantation (01-06-2013)
    “…A single dose of the anti‐CD20 monoclonal antibody rituximab induces a nearly complete B cell depletion in peripheral blood, but not in secondary lymphoid…”
    Get full text
    Journal Article
  2. 2

    Assessment of splenic function by de Porto, A. P. N. A., Lammers, A. J. J., Bennink, R. J., ten Berge, I. J. M., Speelman, P., Hoekstra, J. B. L.

    “…Hyposplenic patients are at risk of overwhelming post-splenectomy infection (OPSI), which carries mortality of up to 70%. Therefore, preventive measures are…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Cytomegalovirus infection in solid organ transplant recipients by Lumbreras, C., Manuel, O., Len, O., ten Berge, I.J.M., Sgarabotto, D., Hirsch, H.H

    Published in Clinical microbiology and infection (01-09-2014)
    “…Cytomegalovirus (CMV) is the most frequent infectious complication following solid organ transplantation (SOT). The virus, is responsible for both direct…”
    Get full text
    Journal Article
  6. 6

    Immunosuppressive drugs after solid organ transplantation by van Sandwijk, M S, Bemelman, F J, Ten Berge, I J M

    Published in Netherlands journal of medicine (01-07-2013)
    “…In recent years solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better…”
    Get full text
    Journal Article
  7. 7

    The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection by Singh, R., Nieuwdorp, M., ten Berge, I.J.M., Bemelman, F.J., Geerlings, S.E.

    Published in Clinical microbiology and infection (01-11-2014)
    “…This review gives an outline of the indications for faecal microbiota transplantation (FMT) for diseases other than Clostridium difficile (C. difficile)…”
    Get full text
    Journal Article
  8. 8

    BK virus infection in transplant recipients: Clinical manifestations, treatment options and the immune response by AALDEREN, M. C. Van, HEUTINCK, K. M, HUISMAN, C, TEN BERGE, I. J. M

    Published in Netherlands journal of medicine (01-05-2012)
    “…Polyomavirus BK (BKV) is ubiquitously present amongst the general population establishing a latent, seemingly asymptomatic infection in immunocompetent…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Antibody response to a T-cell-independent antigen is preserved after splenic artery embolization for trauma by Olthof, D C, Lammers, A J J, van Leeuwen, E M M, Hoekstra, J B L, ten Berge, I J M, Goslings, J C

    Published in Clinical and vaccine immunology (01-11-2014)
    “…Splenic artery embolization (SAE) is increasingly being used as a nonoperative management strategy for patients with blunt splenic injury following trauma. The…”
    Get full text
    Journal Article
  11. 11

    17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients by Wieten, R.W, Goorhuis, A, Jonker, E.F.F, de Bree, G.J, de Visser, A.W, van Genderen, P.J.J, Remmerswaal, E.B.M, ten Berge, I.J.M, Visser, L.G, Grobusch, M.P, van Leeuwen, E.M.M

    Published in The Journal of infection (01-06-2016)
    “…Summary Background The 17D live attenuated yellow fever (YF) vaccine is contra-indicated in immune-compromised individuals and may elicit a suboptimal…”
    Get full text
    Journal Article
  12. 12

    Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication by van Domselaar, R, de Poot, S A H, Remmerswaal, E B M, Lai, K W, ten Berge, I J M, Bovenschen, N

    Published in Cell death and differentiation (01-03-2013)
    “…Human cytomegalovirus (HCMV) is the most frequent viral cause of congenital defects and HCMV infection in immunocompromised patients may trigger devastating…”
    Get full text
    Journal Article
  13. 13

    Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function by Singh, R., Geerlings, S.E., Peters-Sengers, H., Idu, M.M., Hodiamont, C.J., ten Berge, I.J.M., Bemelman, F.J.

    Published in Transplant infectious disease (01-10-2016)
    “…Background The impact of allograft pyelonephritis (AGPN) on renal allograft function is controversial. In this study, we evaluated the incidence, risk factors,…”
    Get full text
    Journal Article
  14. 14

    Rapid T cell repopulation after rabbit anti‐thymocyte globulin (rATG) treatment is driven mainly by cytomegalovirus by Havenith, S. H. C., Remmerswaal, E. B. M., Bemelman, F. J., Yong, S. L., van Donselaar‐ van der Pant, K. A. M. I., van Lier, R. A. W., ten Berge, I. J. M.

    Published in Clinical and experimental immunology (01-09-2012)
    “…Summary Rabbit anti‐thymocyte globulin (rATG) induces a long‐lasting lymphocytopenia. CD4+ T cells remain depleted for up to 2 years, whereas the CD8+ T cell…”
    Get full text
    Journal Article
  15. 15

    Simulated maximum likelihood estimation in joint models for multiple longitudinal markers and recurrent events of multiple types, in the presence of a terminal event by Hof, M. H., Musoro, J. Z., Geskus, R. B., Struijk, G. H., ten Berge, I. J. M., Zwinderman, A. H.

    Published in Journal of applied statistics (18-11-2017)
    “…In medical studies we are often confronted with complex longitudinal data. During the follow-up period, which can be ended prematurely by a terminal event…”
    Get full text
    Journal Article
  16. 16

    Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years by Klarenbeek, P L, Remmerswaal, E B M, ten Berge, I J M, Doorenspleet, M E, van Schaik, B D C, Esveldt, R E E, Koch, S D, ten Brinke, A, van Kampen, A H C, Bemelman, F J, Tak, P P, Baas, F, de Vries, N, van Lier, R A W

    Published in PLoS pathogens (01-09-2012)
    “…CD8(+) T-cell responses against latent viruses can cover considerable portions of the CD8(+) T-cell compartment for many decades, yet their initiation and…”
    Get full text
    Journal Article
  17. 17

    Agreement on Child Maltreatment Decisions: A Nonrandomized Study on the Effects of Structured Decision-Making by Bartelink, C., van Yperen, T. A., ten Berge, I. J., de Kwaadsteniet, L., Witteman, C. L. M.

    Published in Child & youth care forum (01-10-2014)
    “…Background Practitioners investigating cases of suspected child maltreatment often disagree whether a child is subject to or at risk of abuse or neglect in the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Immunization after renal transplantation: current clinical practice by Struijk, G.H., Lammers, A.J.J., Brinkman, R.J., Lombarts, M.J.M.H., van Vugt, M., van der Pant, K.A.M.I., ten Berge, I.J.M., Bemelman, F.J.

    Published in Transplant infectious disease (01-04-2015)
    “…Background The use of potent immunosuppressive drugs and increased travel by renal transplant recipients (RTR) has augmented the risk for infectious…”
    Get full text
    Journal Article
  20. 20

    Characteristics of alloreactive T cells measured before renal transplantation by van de Berg, P. J. E. J., Yong, S. L., Koch, S. D., Lardy, N., van Donselaar‐van der Pant, K. A. M. I., Florquin, S., Bemelman, F. J., van Lier, R. A. W., ten Berge, I. J. M.

    Published in Clinical and experimental immunology (01-05-2012)
    “…Summary Several assays to measure pre‐existing allospecific T cell immunity in renal transplant candidates have been developed in the past years. In 46…”
    Get full text
    Journal Article